Mead Johnson plans expansion in Evansville
Mead Johnson Nutrition plans to spend nearly $33 million at a southwestern Indiana facility where it plans to start making
powdered infant formula products.
Health Care & Insurance
Articles
Lilly: Alimta improves lung-cancer survival time
Indianapolis-based Eli Lilly and Co. announced today that a clinical trial showed lung cancer patients treated with Lilly
drug Alimta lived about three months longer than those who received the best available care.
Chamber puts support behind Wishard hospital proposal
The Greater Indianapolis Chamber of Commerce announced its support for construction of a new Wishard Hospital and promised
to take a leadership position to help hospital leaders win voter approval for the project.
Hill-Rom begins CEO search under succession plan
Medical equipment supplier Hill-Rom Holdings Inc. said yesterday it has begun a chief executive search to plan for the retirement
of current CEO Peter Soderberg.
Weight-loss challenges at local firms raise money for charity
Employees at five different companies collectively lost 805 pounds over six weeks this summer. They also
raised $805 for Big Brothers/Big Sisters of Central Indiana.
Westfield makes smoking illegal in most public places
The Westfield City Council passed a smoking ban 7-0 last night that will prohibit smoking in most public places, including
outdoor arenas, stadiums and amphitheaters.
UPDATE: Pipeline challenges force Lilly restructuring moves
Since John Lechleiter was named CEO 18 months ago, he’s bet that Eli Lilly and Co. could face down its looming patent challenges
by launching innovative new medicines. Today’s announcement of 5,500 job cuts by the end of 2011 and a restructuring of the
company’s business units ups the ante on that bet, while indicating that it isn’t working yet.
Lilly as an employment destination
Eli Lilly and Co. has experienced a string of setbacks in recent years. Is it still a good place to work?
Lilly reorganization to cut 5,500 positions over 2 years
Eli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.
WellPoint insiders sell stock at right time
Take the money while it’s there. That’s what a handful of insiders at WellPoint Inc. decided in
the past month as they sold off nearly 150,000 company shares for gains of more than $3 million.
On the hook for bariatric surgery
An Indiana Court of Appeals ruling favoring an obese employee is likely to make employers think twice about hiring
overweight people.
Policyholders could pay more under Obama health plan
If President Barack Obama gets what he wants in his health care plan — covering all Americans and barring insurers from
denying coverage — some analysts say individuals could wind up paying higher premiums.
Benefits brokers fear impact of health insurance exchanges
If Congress implements a new system of health insurance exchanges across the country, Indianapolis benefits broker Joe
Guzman is confident he and his peers would take a hit.
Sanctions lifted, WellPoint returns to Medicare biz
Nine months after being suspended as a contractor for the federal Medicare program, WellPoint Inc. is back in the game.
Medical device developer receives $1M in federal funding
Indianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
Lilly paid doctors to prescribe Zyprexa, notes say
Eli Lilly and Co. paid doctors in South Carolina for participating in a speakers’ program in exchange for prescribing the
antipsychotic Zyprexa, according to notes by Lilly sales representatives reviewed by Bloomberg News.
Health information exchanges begin sharing medical records
The Indianapolis-based Indiana Health Information Exchange today began sharing electronic medical records with two similar
organizations across a multi-regional network, the group announced this morning.
Group: Health insurers urged workers to fight reform
A consumer group says health insurers UnitedHealth and WellPoint pressured their employees to contact members of Congress
and lobby against health care reform proposals that the companies disagreed with.
Pfizer to pay record $2.3B penalty over promotions
Pfizer Inc., the world’s largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription
drug promotions, the Justice Department announced today.
WellPoint CEO defends health insurance business
A health care reform push that aims at the insurance industry misses a much bigger target in its quest to lower rising costs,
WellPoint Inc. CEO Angela Braly said in a speech.